ReviewThe host—tumor immune conflict: from immunosuppression to resistance and destruction
References (63)
- et al.
Immunol. Today
(1993) - et al.
Immunol. Today
(1994) - et al.
Immunol. Today
(1997) - et al.
Immunol. Today
(1991) - et al.
Immunol. Today
(1989) - et al.
Blood
(1994) - et al.
Cell
(1990) - et al.
Curr. Opin. Immunol.
(1992) - et al.
Immunol. Today
(1992) - et al.
Cell
(1990)
FEBS Lett.
Lancet
Blood
J. Biol. Chem.
Immunol. Today
Immunol. Today
Blood
Blood
J. Exp. Med.
J. Immunol.
Int. Immunol.
J. Exp. Med.
J. Immunol.
J. Immunol.
J. Immunol.
Cancer Res.
Int. J. Cancer
Int. J. Cancer
J. Immunol.
J. Exp. Med.
Cited by (343)
Neem Leaf Glycoprotein in immunoregulation of cancer
2022, Human ImmunologyBacteria-based immune therapies for cancer treatment
2022, Seminars in Cancer BiologyGinsenoside Rg3 improves cyclophosphamide-induced immunocompetence in Balb/c mice
2019, International ImmunopharmacologyTumor mechanisms of resistance to immune attack
2019, Progress in Molecular Biology and Translational ScienceCitation Excerpt :Cytokines and chemokines in the local environment are critical regulators of immune cell functionality, and tumor cells often exploit them in order to suppress CTL and NK cell activity. It has been well established that tumor cells spontaneously release immunosuppressive cytokines.149 These cytokines and chemokines include transforming growth factor beta (TGF-β), VEGF, prostaglandin E2 (PGE2), IL-10, and Th2 inflammatory mediators.
Immunomodulatory Activity of VEGF in Cancer
2017, International Review of Cell and Molecular BiologyCitation Excerpt :Cells able to produce TGF-β include tumor cells, Tregs, and stromal cells, and TGF-β production has been associated with the growth of a large variety of tumors (Pasche, 2001). TGF-β is the most potent immunosuppressive factor able to reduce the proliferation, activation, and differentiation of immune cells (Chouaib and Blay, 1997). TGF-β inhibits T-cell proliferation by inhibiting IL-2 production (Brabletz and Serfling, 1993).
Roles of ROS mediated oxidative stress and DNA damage in 3-methyl-2-quinoxalin benzenevinylketo-1, 4-dioxide-induced immunotoxicity of Sprague-Dawley rats
2014, Regulatory Toxicology and Pharmacology